P.18.1 A PROPER ORGANIZATIONAL MODEL ENCOURAGES HIGH RATE OF INTENTION-TO-TREAT SUSTAINED VIROLOGICAL RESPONSE IN AN INJECTING DRUG USERS HCV+ POPULATION